Main Session
Oct
01
QP 20 - GU 9: Quick Pitch: Predictive Markers in Prostate Cancer
1116 - Discordance of Adverse Molecular Features between the 22-Gene Genomic Classifier Score, Histologic Grade, and NCCN Risk Groups: Analysis of Over 200,000 Patients
Presenter(s)
Michael Zelefsky, MD, FASTRO - NYU Langone Laura and Isaac Perlmutter Cancer Center, New York, NY